Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Recycling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114014874B reveals a breakthrough recycling method for Baloxavir intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN108137587A details a novel electrochemical recycling method for high-purity naphthyridine intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN113087630A introduces a novel recycling method for (R)-(+)-alpha-phenylethylamine, ensuring high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Novel patent CN105566319A details efficient moxifloxacin intermediate synthesis with high chiral purity and reduced costs for reliable supply chains.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN114014874A reveals a cyclic resolution method for Baloxavir intermediates, significantly reducing waste and improving yield for reliable pharmaceutical intermediate supply chains.
Patent CN108137587B details a novel electrochemical recycling process for Finerenone intermediates, offering significant cost reduction and scalability for API manufacturing.
Patent CN104140430B enables recycling of S-isomers via halogenation. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.